BP602T · Semester 6 · B.Pharm
Unit II — Bioavailability and Bioequivalence
Biopharmaceutics and Pharmacokinetics
This study page introduces Bioavailability and Bioequivalence in Biopharmaceutics and Pharmacokinetics (BP602T), B.Pharm Semester 6. Read the selected definitions and short notes below, then download the full unit PDF.
Topics in this unit
- Bioavailability and Bioequivalence — How Much Reaches the Blood
- BCS, Dissolution Testing, IVIVC, Biowaivers and Bioavailability Enhancement
Definitions and short notes
Selected extracts from this unit’s notes. Download the full PDF below for the remaining topics and examples.
What Is Bioavailability? (Start From Zero)
Bioavailability (F) is the rate and extent to which the active drug reaches the systemic circulation unchanged. Objectives: (a) to know how much of the dose actually works, (b) to compare formulations (generic vs innovator), (c) to design correct doses.
Unit PDF · page 2
Download notes
Save the PDF for offline reading. On some browsers, the file opens first; use the PDF viewer’s download button to save it.
For education and exam preparation only, not medical advice or current regulatory guidance.